Valero-López, G; Carreon-Guarnizo, Ester; Hernández-Clares, R; Iniesta-Martínez, F; Jiménez-Veiga, J; Moreno-Docon, A; Iborra-Bendicho, M-A; Aznar-Robles, E; Hellin-Gil, M-F; Morales-Ortiz, A; Meca-Lallana, J-E
(ELSEVIER ESPANA SLU, 2020-07)
INTRODUCTION: The COVID-19 pandemic is changing approaches to diagnosis, treatment, and care provision in multiple sclerosis (MS). During both the initial and peak phases of the epidemic, the administration of disease-modifying ...